Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3aJennifer R. Deuis, Irina Vetter, Michael S. Minett et al.|Scientific Reports|2017Cited by 139
Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated PainJennifer R. Deuis, Irina Vetter, Joshua S. Wingerd et al.|Toxins|2016Cited by 116
Characterisation of Nav types endogenously expressed in human SH-SY5Y neuroblastoma cellsIrina Vetter, Richard J. Lewis, Christine A. Mozar et al.|Biochemical Pharmacology|2012Cited by 83
Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingiSilmara Rodrigues de Sousa, Richard J. Lewis, Joshua S. Wingerd et al.|PLoS ONE|2017Cited by 33
Multitarget nociceptor sensitization by a promiscuous peptide from the venom of the King Baboon spiderRocio K. Finol‐Urdaneta, Paul F. Alewood, Rebekah Ziegman et al.|Proceedings of the National Academy of Sciences|2022Cited by 20